BSE · ACHYUT.BO
Achyut Healthcare Ltd.
₹8.29+₹0.12 (+1.47%)
Achyut Healthcare Ltd.’s quoted price sits in the upper half of its reported 52-week range, 17.43% below the high.
Loading market information…
NSE · BALPHARMA.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:41 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Bal Pharma Limited’s quoted price sits in the lower half of its reported 52-week range, 34.79% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Bal Pharma Limited’s forward annual dividend is ₹1.20 per share, paid annual. The forward yield is 1.48% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Bal Pharma Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs. It also provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostate enlargement, renal calculi, male infertility, and women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; herbal liver protective and antioxidant; and cardiac care products under the Secremet and Servace brands. In addition, the company offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment, etc.; and various formulations, including tablets, capsules, syrups, suspensions, ophthalmic, creams, and ointments. Further, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. The company exports its products to approximately 30 countries. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹8.29+₹0.12 (+1.47%)
Achyut Healthcare Ltd.’s quoted price sits in the upper half of its reported 52-week range, 17.43% below the high.
₹114.67-₹6.03 (-5.0%)
Par Drugs and Chemicals Limited’s quoted price sits in the lower half of its reported 52-week range, 36.29% below the high.
₹57.50-₹0.43 (-0.74%)
Krebs Biochemicals & Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 25.18% below the high.
₹103.80+₹0.75 (+0.73%)
Tyche Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 29.86% below the high.
₹6.68-₹0.14 (-2.05%)
Vaishali Pharma Limited’s quoted price sits in the lower half of its reported 52-week range, 36.07% below the high.
₹60.52-₹1.11 (-1.8%)
Denis Chem Lab Limited’s quoted price sits in the lower half of its reported 52-week range, 36.03% below the high.
₹39.61-₹0.91 (-2.25%)
Fortis Malar Hospitals Limited’s quoted price sits in the lower half of its reported 52-week range, 41.7% below the high.
₹29.18-₹0.04 (-0.14%)
Mangalam Drugs & Organics Limited’s quoted price sits in the lower half of its reported 52-week range, 57.34% below the high.
